About
Bio
Circulation:
A circulation figure is not currently available.
Aims of the journal:
As a bimonthly, peer-reviewed journal, International Journal of Haematologic Oncology will be a key resource for clinicians and researchers alike within the haematologic oncology community by delivering clear, concise and comprehensive articles with a high-quality format.
International Journal of Haematologic Oncology is dedicated to presenting the latest and most promising progresses and discoveries in the study of haematologic malignancies and its related fields. The journal provides a forum for the discussion and analysis of emerging advancements in diagnosis, treatment strategies and novel targeted therapies, with an added focus on the overall management of haematologic malignancies and evaluation of prospects for further development.
Content:
Coverage includes:
All forms of haematologic malignancies including leukemia, lymphoma, myeloma and related diseases
Epidemiology and pathology of the disease types
Medical oncology - the diagnosis and management of haematologic cancers
Imaging and radiology
Advances in chemotherapy
Surgical oncology
Prospects for new treatments such as stem cell therapy and immunotherapy
Analysis and critique on promising new drug developments in the field
Clinical research updates
Policy and medical treatment guidelines
Palliative care
Paediatric and ageing health
Editorial contacts:
Editorial queries can be directed to Sebastian Dennis - Baron at s.dennis-beron@futuremedicine.com
For Drug Evaluations, contact Henry Ireland at h.ireland@futuremedicine.com
The Editorial Board members can be viewed here
Manuscript submission:
Instructions for authors and editorial guidelines can be viewed here
Average Lead Time to Online Publication: 14 - 16 weeks
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Hematology, Oncology
Bio
Circulation: A circulation figure is not currently available. Aims of the journal: As a bimonthly, peer-reviewed journal, International Journal of Haematologic Oncology will be a key resource for clinicians and researchers alike within the haematologic oncology community by delivering clear, concise and comprehensive articles with a high-quality format. International Journal of Haematologic Oncology is dedicated to presenting the latest and most promising progresses and discoveries in the study of haematologic malignancies and its related fields. The journal provides a forum for the discussion and analysis of emerging advancements in diagnosis, treatment strategies and novel targeted therapies, with an added focus on the overall management of haematologic malignancies and evaluation of prospects for further development. Content: Coverage includes: All forms of haematologic malignancies including leukemia, lymphoma, myeloma and related diseases Epidemiology and pathology of the disease types Medical oncology - the diagnosis and management of haematologic cancers Imaging and radiology Advances in chemotherapy Surgical oncology Prospects for new treatments such as stem cell therapy and immunotherapy Analysis and critique on promising new drug developments in the field Clinical research updates Policy and medical treatment guidelines Palliative care Paediatric and ageing health Editorial contacts: Editorial queries can be directed to Sebastian Dennis - Baron at s.dennis-beron@futuremedicine.com For Drug Evaluations, contact Henry Ireland at h.ireland@futuremedicine.com The Editorial Board members can be viewed here Manuscript submission: Instructions for authors and editorial guidelines can be viewed here Average Lead Time to Online Publication: 14 - 16 weeks
Website
Social media
Location
Frequency
Circulation
Sectors
Hematology, Oncology
Most recent articles by International Journal of Hematologic Oncology
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to International Journal of Hematologic Oncology
-
OOncologyLive
Established in 2000 as Oncology Net Guide and rebranded in March 2011 as OncLive. Written for physicians to enable them to keep up to date with the rapidly expanding amount of medical information and resources on oncology. Designed as a handbook for frequent referencing and written in an easy-to-understand style. Articles are quick-reading, timely, provides practical information and information about new medical treatments. Media Alert: Tuesday April 12th 2011 Oncology Net Guide has changed its name to OncLive. Anita Shaffer is Associate Editor in charge of the oncology research and technology magazine. She may be reached at +1 (609) 716 7777 Ext 192 and ashaffer@onclive.com
ViewTTargeted OncologyTargeted Oncology is an online resource for oncology news and research, carrying content from Intellisphere's printed oncology journals, Targeted Therapies and The Journal of Targeted Therapies.
ViewMMedical News TodayBackground and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.
ViewTThe Lancet OncologyImpact Factor: 26.509 (Source:Thomson Reuters Journal Citation 2016) Format and Background: The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Circulation: The Publisher does not disclose the circulation. Aims of the journal: The Lancet Oncology was launched in September 2000 with the aim of being a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. In May 2005, the journal expanded to include original research and began publishing articles online first prior to print publication. In 2008, the journal expanded its online presence to include regular podcasts. The aim of The Lancet Oncology is to publish interesting, informative, and practice-changing articles on any topic connected with clinical oncology. Readership: Clinical cancer specialists worldwide. Content: Topics include, but are not limited to: Breast cancer Endocrine system cancer Gastrointestinal cancer Genitourinary cancer Gynaecological cancer Haematological cancer Head and neck cancer Neurooncology Paediatric oncology Thoracic oncology Sarcoma Skin cancer Epidemiology, cancer prevention, and cancer control Supportive care Imaging Health-care systems Manuscript submission: The journal publishes a range of article types that encompass all aspects of oncological medicine: Comment, Correspondence, News, Cancer and Society, Article, Meta-analysis, Review, Historical Review, Health-care Development, Personal View, and Debate. For further information for authors, click here. Online manuscripts submission here. Ad Rates: Can be viewed here the advertising team can be reached at lancet-ads@elsevier.com Other Information: The RSS feed can be viewed here Podcasts can be found here Information for the press can be viewed here
ViewJJAMA OncologySet to launch in February 2015, this medical journal aimed at physicians covers oncology. Will feature all aspects of medical, radiation, and surgical oncology and its subspecialties
ViewUse CisionOne to find more relevant outletsContact International Journal of Hematologic Oncology and get access to over 850K accurate, up-to-date media profiles.
Discover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.